2m 2m 2m 2m 2m 2m 2m
Supernus Pharm (SUPN)
NASDAQ
$42.39+$0.20 (+0.49%)
Price as of Oct 02, 2026 5:49 PM EDT- $2.5BMarket Cap
- -12.05%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Supernus Pharm (SUPN)
$42.39+$0.20 (+0.49%)
SUPN | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $42.18 | ||
Change | -$0.86 (-2.00%) | ||
Open | $43.21 | ||
High | $43.69 | ||
Low | $42.15 | ||
Previous Close | $43.04 | ||
Volume | 424,631 | ||
30-Day Average Volume | 627,112 | ||
1-Week Change | -2.56% | ||
1-Month Change | -3.57% | ||
1-Year Change | -12.05% | ||
3-Year Change | 52.99% | ||
5-Year Change | 54.96% | ||
Fundamentals | |||
Shares Outstanding | 58.2M | ||
Total Assets | $1.4B | ||
Market Cap | $2.5B | ||
Enterprise Value | $2.3B | ||
Period: QTR TTM FY | |||
Revenue | $165.7M | ||
Net Income | -$58.4M | ||
Free Cash Flow | -$5.4M | ||
EBIT | -$57.6M | ||
EBITDA | -$31.9M | ||
Net Working Capital | $376.1M | ||
EPS | -$1.01 | ||
Enterprise Value/EBITDA | -71 | ||
Enterprise Value/Revenue | 14 | ||
P/B | 2 | ||
P/E | -42 | ||
PEG | 0 | ||
Price/Free Cash Flow | -457 | ||
Price/Operating Cash Flow | -511 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue